Gaza is vaccinating against polio. Is the virus a threat to the U.S.?
A campaign is ongoing to vaccinate children in Gaza after its first polio case in 25 years. The threat to the United States is only in communities with low vaccination levels.
By Mark JohnsonTrump struggles to embrace ‘lousy’ Obamacare, calling again to replace it
The former president admits he has only “concepts of a plan” to replace the health law, after years of trying to do away with it.
By Dan DiamondWhat Kamala Harris learned from embracing, abandoning Medicare-for-all
The vice president now believes that incremental change, not a sweeping overhaul, is the best path to improving U.S. health care.
By Dan Diamond9/11 responders are getting dementia. They want the government to help.
Research shows 9/11 responders face higher rates of dementia and cognitive impairment.
By Dan HurleyAbortion takes center stage at debate; déjà vu on Obamacare
The Washington Post’s essential guide to health policy news.
By Rachel RoubeinBoar’s Head plant posed an ‘imminent threat’ years before listeria outbreak
Inspectors discovered rusted equipment, condensation dripping on the floor and green mold on the wall two years before a deadly nationwide listeria outbreak.
By Rachel RoubeinAndrew Cuomo, once a covid star, grilled by Congress over pandemic missteps
Lawmakers berated the former New York governor over his 2020 order that forced the state’s nursing homes to readmit more than 9,000 covid-positive patients.
By Dan DiamondHarris and Trump are ready to take on Big Pharma
The track records of Vice President Kamala Harris and former president Donald Trump on drug pricing suggest either ticket would take an aggressive approach to try to curb prescription drug costs.
By Stephanie Armour and Sabrina MalhiTrump signals support for Biden plan to loosen marijuana restrictions
The former president suggests he wants to see marijuana reclassified as a Schedule III drug, the first time Trump has endorsed the easing of federal restrictions.
By David Ovalle and Patrick SvitekBabesiosis, another disease spread by ticks, is on the rise
Babesiosis is on the rise and can be serious, especially for people who are immunocompromised.
By Kevin LoriaMpox vaccines arrive in Congo
The Washington Post’s essential guide to health policy news.
By Fenit Nirappil and Sabrina MalhiFor caregivers, a friend who ‘gets it’ can be a lifeline
Illness can be isolating, making caregiving that much harder. Just one person can change everything.
By Abby Alten SchwartzLecture playlist delves into the wide world of medical history
The National Library of Medicine offers a wide-ranging series of online lectures on the history of medicine as seen through the lens of the world’s largest biomedical library.
By Erin BlakemoreMedical Mysteries: Her runny nose signaled something more serious
Doctors thought her constantly running nose was due to allergies or a virus. Eight years earlier, a relative had a similar problem that had an unfortunate ending.
By Sandra G. BoodmanOnly 61 percent of teens have been fully vaccinated against HPV
If used before HPV exposure, the completed vaccination series can protect against 92 percent of cancers associated with the virus.
By Ian McMahanBird flu explained: How it spreads, milk and egg safety and more
Here’s what to know about avian influenza, its symptoms and treatment, and its risk to humans and pets.
By Lindsey Bever, Annabelle Timsit, Rachel Roubein, Lena H. Sun and Victoria BissetBird flu detected in Missouri individual who is not a farm worker
This is the 14th human case of bird flu reported this year in the United States and the first without a known occupational exposure to infected animals.
By Lena H. SunScientists use food dye found in Doritos to make see-through mice
Food dye transformed the skin of mice into a living window revealing blood vessels, muscle fibers and gut contractions, according to a new study.
By Carolyn Y. JohnsonYouth vaping on the decline, federal survey shows
Nearly 6 percent of U.S. middle and high school students reported using e-cigarettes this year compared to last year’s 7.7 percent.
By Rachel Roubein and David OvalleFDA gives an early nod to psychedelic research
The Washington Post’s essential guide to health policy news.
By David Ovalle and McKenzie Beard